{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:12:41Z","timestamp":1790885561164,"version":"4.1.0"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008993","name":"Sveu\u010dili\u0161te u Zagrebu","doi-asserted-by":"publisher","award":["10106-22-3071"],"award-info":[{"award-number":["10106-22-3071"]}],"id":[{"id":"10.13039\/100008993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10787-024-01499-8","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T11:01:59Z","timestamp":1720522919000},"page":"3119-3161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion\/occlusion-like syndrome in cytoprotection\/organoprotection"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7952-2252","authenticated-orcid":false,"given":"Predrag","family":"Sikiric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Krezic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Vranes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Kalogjera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Maria","family":"Smoday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasta","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Oroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Coric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Skoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Kavelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Zubcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suncana","family":"Sikiric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Beketic Oreskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Oreskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Blagaic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Brcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Strbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Staresinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka","family":"Boban Blagaic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Skrtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Seiwerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"2","key":"1499_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/molecules28020619","volume":"28","author":"RS Aleman","year":"2023","unstructured":"Aleman RS, Moncada M, Aryana KJ (2023) Leaky gut and the ingredients that help treat it: a review. Molecules 28(2):619","journal-title":"Molecules"},{"issue":"47","key":"1499_CR2","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.3748\/wjg.v24.i47.5366","volume":"24","author":"F Amic","year":"2018","unstructured":"Amic F, Drmic D, Bilic Z et al (2018) Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157 L-NAME and L-Arginine. World J Gastroenterol 24(47):5366\u20135378","journal-title":"World J Gastroenterol"},{"issue":"40","key":"1499_CR3","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","volume":"22","author":"G Anderson","year":"2016","unstructured":"Anderson G, Seo M, Berk M et al (2016) Gut permeability and microbiota in Parkinson\u2019s disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways. Curr Pharm Des 22(40):6142\u20136151","journal-title":"Curr Pharm Des"},{"issue":"1\u20133","key":"1499_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.regpep.2009.05.008","volume":"156","author":"D Balenovic","year":"2009","unstructured":"Balenovic D, Bencic ML, Udovicic M et al (2009) Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. Regul Pept 156(1\u20133):83\u201389","journal-title":"Regul Pept"},{"key":"1499_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.lfs.2016.02.029","volume":"148","author":"M Baric","year":"2016","unstructured":"Baric M, Sever AZ, Vuletic LB et al (2016) Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats. Life Sci 148:63\u201370","journal-title":"Life Sci"},{"key":"1499_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.regpep.2012.12.007","volume":"181","author":"I Barisic","year":"2013","unstructured":"Barisic I, Balenovic D, Klicek R et al (2013) Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157. Regul Pept 181:50\u201366","journal-title":"Regul Pept"},{"issue":"2","key":"1499_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/biomedicines10020265","volume":"10","author":"I Barisic","year":"2022","unstructured":"Barisic I, Balenovic D, Udovicic M et al (2022) Stable gastric pentadecapeptide BPC 157 may counteract myocardial infarction induced by isoprenaline in rats. Biomedicines 10(2):265","journal-title":"Biomedicines"},{"issue":"3","key":"1499_CR8","first-page":"429","volume":"69","author":"T Becejac","year":"2018","unstructured":"Becejac T, Cesarec V, Drmic D et al (2018) An endogenous defensive concept, renewed cytoprotection\/adaptive cytoprotection: intra(per)-oral\/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system. J Physiol Pharmacol 69(3):429\u2013440","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"1499_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2003.08.013","volume":"477","author":"V Bedekovic","year":"2003","unstructured":"Bedekovic V, Mise S, Anic T et al (2003) Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy. Eur J Pharmacol 477(1):73\u201380","journal-title":"Eur J Pharmacol"},{"key":"1499_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10787-017-0358-8","volume":"25","author":"Z Belosic Halle","year":"2017","unstructured":"Belosic Halle Z, Vlainic J, Drmic D et al (2017) Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine. Inflammopharmacology 25:511\u2013522","journal-title":"Inflammopharmacology"},{"issue":"16","key":"1499_CR11","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0024-3205(00)01025-0","volume":"68","author":"I Bilic","year":"2001","unstructured":"Bilic I, Zoricic I, Anic T et al (2001) Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life Sci 68(16):1905\u20131912","journal-title":"Life Sci"},{"issue":"3","key":"1499_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.burns.2004.10.013","volume":"31","author":"M Bilic","year":"2005","unstructured":"Bilic M, Bumber Z, Blagaic AB et al (2005) The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice. Burns 31(3):310\u2013315","journal-title":"Burns"},{"issue":"6","key":"1499_CR13","first-page":"939","volume":"72","author":"Z Bilic","year":"2021","unstructured":"Bilic Z, Gojkovic S, Kalogjera L et al (2021) Novel insight into Robert\u2019s cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pantoprazole therapy and L-NG-nitro-L-arginine methyl ester worsening. J Physiol Pharmacol 72(6):939\u2013955","journal-title":"J Physiol Pharmacol"},{"issue":"3\u20135","key":"1499_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0928-4257(97)89482-X","volume":"91","author":"B B\u00f3dis","year":"1997","unstructured":"B\u00f3dis B, Kar\u00e1di O, Nagy L et al (1997a) Direct cellular effects of some mediators, hormones and growth factor-like agents on denervated (isolated) rat gastric mucosal cells. J Physiol Paris 91(3\u20135):183\u2013187","journal-title":"J Physiol Paris"},{"issue":"16","key":"1499_CR15","doi-asserted-by":"publisher","first-page":"PL243","DOI":"10.1016\/S0024-3205(97)00744-3","volume":"61","author":"B B\u00f3dis","year":"1997","unstructured":"B\u00f3dis B, Kar\u00e1di O, N\u00e9meth P et al (1997b) Evidence for direct cellular protective effect of PL-10 substances (synthesized parts of body protection compound, BPC) and their specificity to gastric mucosal cells. Life Sci 61(16):PL243-248","journal-title":"Life Sci"},{"issue":"Suppl 7","key":"1499_CR16","first-page":"191","volume":"60","author":"L Brcic","year":"2009","unstructured":"Brcic L, Brcic I, Staresinic M et al (2009) Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol 60(Suppl 7):191\u2013196","journal-title":"J Physiol Pharmacol"},{"issue":"8","key":"1499_CR17","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camillleri","year":"2019","unstructured":"Camillleri M (2019) Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 68(8):1516\u20131526","journal-title":"Gut"},{"key":"1499_CR200","doi-asserted-by":"crossref","unstructured":"Cerovecki T, Bojanic I, Brcic L et al (2010) Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res 28(9):1155\u20131161","DOI":"10.1002\/jor.21107"},{"issue":"1\u20133","key":"1499_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejphar.2012.11.055","volume":"701","author":"V Cesarec","year":"2013","unstructured":"Cesarec V, Becejac T, Misic M et al (2013) Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy. Eur J Pharmacol 701(1\u20133):203\u2013212","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1499_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1152\/japplphysiol.00945.2010","volume":"110","author":"CH Chang","year":"2011","unstructured":"Chang CH, Tsai WC, Lin MS et al\u00a0 (2011) The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol 110(3):774\u2013780","journal-title":"J Appl Physiol"},{"key":"1499_CR20","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.3390\/molecules191119066","volume":"19","author":"CH Chang","year":"2014","unstructured":"Chang CH, Tsai WC, Hsu YH et al (2014) Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules 19:19066\u201319077","journal-title":"Molecules"},{"key":"1499_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2165\/00023210-200418030-00004","volume":"18","author":"SM Cheer","year":"2004","unstructured":"Cheer SM, Wagstaff AJ (2004) Quetiapine. A review of its use in the management of schizophrenia. CNS Drugs 18:173\u2013199","journal-title":"CNS Drugs"},{"issue":"16","key":"1499_CR22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2174\/138161211796197007","volume":"17","author":"X Deng","year":"2011","unstructured":"Deng X, Szabo S, Chen L et al (2011) New cell therapy using bone marrow-derived stem cells\/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis. Curr Pharm Des 17(16):1643\u20131651","journal-title":"Curr Pharm Des"},{"issue":"41","key":"1499_CR23","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.3748\/wjg.v22.i41.9127","volume":"22","author":"Z Djakovic","year":"2016","unstructured":"Djakovic Z, Djakovic I, Cesarec V et al (2016) Esophagogastric anastomosis in rats: improved healing by BPC 157 and L-arginine, aggravated by L-NAME. World J Gastroenterol 22(41):9127\u20139140","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1499_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1254\/jphs.FP0061322","volume":"104","author":"I Dobric","year":"2007","unstructured":"Dobric I, Drvis P, Petrovic I et al (2007) Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157. J Pharmacol Sci 104(1):7\u201318","journal-title":"J Pharmacol Sci"},{"issue":"Suppl 2","key":"1499_CR25","first-page":"S53","volume":"61","author":"JR Docherty","year":"2021","unstructured":"Docherty JR, Alsufyani HA (2021) Pharmacology of drugs used as stimulants. J Clin Pharmacol 61(Suppl 2):S53\u2013S69","journal-title":"J Clin Pharmacol"},{"issue":"48","key":"1499_CR26","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.3748\/wjg.v24.i48.5462","volume":"24","author":"D Drmic","year":"2018","unstructured":"Drmic D, Samara M, Vidovic T et al (2018) Counteraction of perforated cecum lesions in rats: effects of pentadecapeptide BPC 157 L-NAME and L-Arginine. World J Gastroenterol 24(48):5462\u20135476","journal-title":"World J Gastroenterol"},{"key":"1499_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2014.01.046","volume":"727","author":"B Duplancic","year":"2014","unstructured":"Duplancic B, Stambolija V, Holjevac J et al (2014) Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration. Eur J Pharmacol 727:75\u201379","journal-title":"Eur J Pharmacol"},{"issue":"48","key":"1499_CR28","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.3748\/wjg.v23.i48.8465","volume":"23","author":"A Duzel","year":"2017","unstructured":"Duzel A, Vlainic J, Antunovic M et al (2017) Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: new insights. World J Gastroenterol 23(48):8465\u20138488","journal-title":"World J Gastroenterol"},{"issue":"3\u20135","key":"1499_CR199","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0928-4257(97)89481-8","volume":"91","author":"D Erceg","year":"1997","unstructured":"Erceg D, Simicevic VN, Kolega M et al (1997) Some aspects of the effects of PL-10.1.AK-15 on the gastrointestinal tract. J Physiol Paris 91(3\u20135):179\u2013181","journal-title":"J Physiol Paris"},{"issue":"4","key":"1499_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/joim.12584","volume":"281","author":"L F\u00e4ndriks","year":"2017","unstructured":"F\u00e4ndriks L (2017) Roles of the gut in the metabolic syndrome: an overview. J Intern Med 281(4):319\u2013336","journal-title":"J Intern Med"},{"key":"1499_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fnana.2019.00048","volume":"13","author":"M Ferrucci","year":"2019","unstructured":"Ferrucci M, Limanaqi F, Ryskalin L, Biagioni F, Busceti CL, Fornai F (2019) The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine and acetylcholine from the brainstem reticular formation. Front Neuroanat 13:48","journal-title":"Front Neuroanat"},{"issue":"S1","key":"1499_CR31","first-page":"667","volume":"31","author":"A Filosevic","year":"2018","unstructured":"Filosevic A, Andretic Waldowski R, Sikiric P et al (2018) Stable gastric pentadecapeptide BPC 157 antagonizes hydrogen peroxide induced oxidative stress in Drosophila melanogaster. FASEB J 31(S1):667","journal-title":"FASEB J"},{"issue":"4","key":"1499_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/00000658-199110000-00006","volume":"214","author":"J Folkman","year":"1991","unstructured":"Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y (1991) Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214(4):414\u2013425","journal-title":"Ann Surg"},{"issue":"12","key":"1499_CR33","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/biomedicines10123130","volume":"10","author":"O Gamulin","year":"2022","unstructured":"Gamulin O, Oroz K, Coric L et al (2022) Fourier transform infrared spectroscopy reveals molecular changes in blood vessels of rats treated with pentadecapeptide BPC 156. Biomedicines 10(12):3130","journal-title":"Biomedicines"},{"issue":"1\u20133","key":"1499_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.regpep.2009.11.005","volume":"160","author":"M Gjurasin","year":"2010","unstructured":"Gjurasin M, Miklic P, Zupancic B et al (2010) Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury. Regul Pept 160(1\u20133):33\u201341","journal-title":"Regul Pept"},{"issue":"3","key":"1499_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0165-0173(91)90012-W","volume":"16","author":"GB Glavin","year":"1991","unstructured":"Glavin GB, Murison R, Overmier JB et al (1991) The neurobiology of stress ulcers. Brain Res Brain Res Rev 16(3):301\u2013343","journal-title":"Brain Res Brain Res Rev"},{"issue":"1","key":"1499_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v11.i1.1","volume":"11","author":"S Gojkovic","year":"2020","unstructured":"Gojkovic S, Krezic I, Vrdoljak B et al (2020) Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats. World J Gastrointest Pathophysiol 11(1):1\u201319","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"7","key":"1499_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/biomedicines9070744","volume":"9","author":"S Gojkovic","year":"2021","unstructured":"Gojkovic S, Krezic I, Vranes H et al (2021a) BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment. Biomedicines 9(7):744","journal-title":"Biomedicines"},{"issue":"10","key":"1499_CR38","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3390\/biomedicines9101300","volume":"9","author":"S Gojkovic","year":"2021","unstructured":"Gojkovic S, Krezic I, Vranes H et al (2021b) Robert\u2019s intragastric alcohol-induced gastric lesion model as an escalated general peripheral and central syndrome, counteracted by the stable gastric pentadecapeptide BPC 157. Biomedicines 9(10):1300","journal-title":"Biomedicines"},{"issue":"3\u20135","key":"1499_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0928-4257(97)89478-8","volume":"91","author":"Z Grabarevic","year":"1997","unstructured":"Grabarevic Z, Tisljar M, Artukovic B et al (1997) The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicken. J Physiol Paris 91(3\u20135):139\u2013149","journal-title":"J Physiol Paris"},{"key":"1499_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2016.02.038","volume":"780","author":"T Grgic","year":"2016","unstructured":"Grgic T, Grgic D, Drmic D et al (2016) Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula. Eur J Pharmacol 780:1\u20137","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1499_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/microorganisms7050121","volume":"7","author":"H Gupta","year":"2019","unstructured":"Gupta H, Youn GS, Shin MJ et al (2019) Role of gut microbiota in hepatocarcinogenesis. Microorganisms 7(5):7","journal-title":"Microorganisms"},{"issue":"1","key":"1499_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0016-5085(79)80133-X","volume":"76","author":"PH Guth","year":"1979","unstructured":"Guth PH, Aures D, Paulsen G (1979) Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine and probanthine. Gastroenterology 76(1):88\u201393","journal-title":"Gastroenterology"},{"issue":"2","key":"1499_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jnr.490090206","volume":"9","author":"DE Hernandez","year":"1983","unstructured":"Hernandez DE, Nemeroff CB, Orlando RC et al (1983) The effect of centrally administered neuropeptides on the development of stress-induced gastric ulcers in rats. J Neurosci Res 9(2):145\u2013157","journal-title":"J Neurosci Res"},{"issue":"Suppl 7","key":"1499_CR44","first-page":"161","volume":"60","author":"M Hrelec","year":"2009","unstructured":"Hrelec M, Klicek R, Brcic L et al (2009) Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy. J Physiol Pharmacol 60(Suppl 7):161\u2013165","journal-title":"J Physiol Pharmacol"},{"key":"1499_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00109-016-1488-y","volume":"95","author":"MJ Hsieh","year":"2017","unstructured":"Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS et al (2017) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med 95:323\u2013333","journal-title":"J Mol Med"},{"key":"1499_CR46","doi-asserted-by":"publisher","first-page":"17078","DOI":"10.1038\/s41598-020-74022-y","volume":"10","author":"MJ Hsieh","year":"2020","unstructured":"Hsieh MJ, Lee CH, Chueh HY et al (2020) Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep 10:17078","journal-title":"Sci Rep"},{"key":"1499_CR47","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2147\/DDDT.S82030","volume":"9","author":"T Huang","year":"2015","unstructured":"Huang T, Zhang K, Sun L et al (2015) Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther 9:2485\u20132499","journal-title":"Drug Des Devel Ther"},{"key":"1499_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121072","volume":"310","author":"BS Huang","year":"2022","unstructured":"Huang BS, Huang SC, Chen FH et al (2022) Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro. Life Sci 310:121072","journal-title":"Life Sci"},{"issue":"Suppl 7","key":"1499_CR49","first-page":"107","volume":"60","author":"S Ilic","year":"2009","unstructured":"Ilic S, Brcic I, Mester M et al (2009) Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats. J Physiol Pharmacol 60(Suppl 7):107\u2013114","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"1499_CR50","first-page":"241","volume":"61","author":"S Ilic","year":"2010","unstructured":"Ilic S, Drmic D, Zarkovic K et al (2010) High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736). J Physiol Pharmacol 61(2):241\u2013250","journal-title":"J Physiol Pharmacol"},{"issue":"11\u201312","key":"1499_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.lfs.2011.01.015","volume":"88","author":"S Ilic","year":"2011","unstructured":"Ilic S, Drmic D, Franjic S et al (2011a) Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Life Sci 88(11\u201312):535\u2013542","journal-title":"Life Sci"},{"issue":"1\u20133","key":"1499_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejphar.2011.05.038","volume":"667","author":"S Ilic","year":"2011","unstructured":"Ilic S, Drmic D, Zarkovic K et al (2011b) Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. Eur J Pharmacol 667(1\u20133):322\u2013329","journal-title":"Eur J Pharmacol"},{"key":"1499_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.12659\/MSMBR.883828","volume":"19","author":"I Jandric","year":"2013","unstructured":"Jandric I, Vrcic H, Jandric Balen M et al (2013) Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats. Med Sci Monit Basic Res 19:93\u2013102","journal-title":"Med Sci Monit Basic Res"},{"issue":"11","key":"1499_CR54","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/biomedicines9111547","volume":"9","author":"M Japjec","year":"2021","unstructured":"Japjec M, Horvat Pavlov K, Petrovic A et al (2021) Stable gastric pentadecapeptide BPC 157 as a therapy for the disable myotendinous junction in rats. Biomedicines 9(11):1547","journal-title":"Biomedicines"},{"issue":"1","key":"1499_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-2999(99)00486-0","volume":"379","author":"N Jelovac","year":"1999","unstructured":"Jelovac N, Sikiric P, Rucman R et al (1999) Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. Eur J Pharmacol 379(1):19\u201331","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1499_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.17245\/jdapm.2022.22.2.97","volume":"22","author":"YH Jung","year":"2022","unstructured":"Jung YH, Kim H, Kim H et al (2022) The anti-nociceptive effect of BPC-157 on the incisional pain model in rats. J Dent Anesth Pain Med 22(2):97\u2013105","journal-title":"J Dent Anesth Pain Med"},{"issue":"27","key":"1499_CR57","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.3748\/wjg.v29.i27.4289","volume":"29","author":"L Kalogjera","year":"2023","unstructured":"Kalogjera L, Krezic I, Smoday IM et al (2023) Stomach perforation-induced general occlusion\/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect. World J Gastroenterol 29(27):4289\u20134316","journal-title":"World J Gastroenterol"},{"issue":"18","key":"1499_CR58","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2174\/1381612824666180614082950","volume":"24","author":"EA Kang","year":"2018","unstructured":"Kang EA, Han YM, An JM et al (2018) BPC157 as potential agent rescuing from cancer cachexia. Curr Pharm Des 24(18):1947\u20131956","journal-title":"Curr Pharm Des"},{"issue":"Suppl 7","key":"1499_CR59","first-page":"115","volume":"60","author":"B Keremi","year":"2009","unstructured":"Keremi B, Lohinai Z, Komora P et al (2009) Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. J Physiol Pharmacol 60(Suppl 7):115\u2013122","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"1499_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1254\/jphs.FP0072161","volume":"108","author":"R Klicek","year":"2008","unstructured":"Klicek R, Sever M, Radic B et al (2008) Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. J Pharmacol Sci 108(1):7\u201317","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"1499_CR61","first-page":"597","volume":"64","author":"R Klicek","year":"2013","unstructured":"Klicek R, Kolenc D, Suran J et al (2013) Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability. J Physiol Pharmacol 64(5):597\u2013612","journal-title":"J Physiol Pharmacol"},{"issue":"8","key":"1499_CR62","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/biomedicines9081029","volume":"9","author":"M Knezevic","year":"2021","unstructured":"Knezevic M, Gojkovic S, Krezic I et al (2021a) Complex syndrome of the complete occlusion of the end of the superior mesenteric vein opposed with the stable gastric pentadecapeptide BPC 157 in rats. Biomedicines 9(8):1029","journal-title":"Biomedicines"},{"issue":"7","key":"1499_CR63","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/biomedicines9070792","volume":"9","author":"M Knezevic","year":"2021","unstructured":"Knezevic M, Gojkovic S, Krezic I et al (2021b) Occluded superior mesenteric artery and vein. Therapy with the stable gastric pentadecapeptide BPC 157. Biomedicines 9(7):792","journal-title":"Biomedicines"},{"issue":"6","key":"1499_CR64","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/biomedicines9060609","volume":"9","author":"M Knezevic","year":"2021","unstructured":"Knezevic M, Gojkovic S, Krezic I et al (2021c) Occlusion of the superior mesenteric artery in rats reversed by collateral pathways activation: gastric pentadecapeptide BPC 157 therapy counteracts multiple organ dysfunction syndrome; intracranial, portal, and caval hypertension; and aortal hypotension. Biomedicines 9(6):609","journal-title":"Biomedicines"},{"key":"1499_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejphar.2015.12.016","volume":"771","author":"A Kokot","year":"2016","unstructured":"Kokot A, Zlatar M, Stupnisek M et al (2016) NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: reversal by the pentadecapeptide BPC 157 in rats and guinea pigs. Eur J Pharmacol 771:211\u2013219","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1499_CR66","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4254\/wjh.v12.i5.184","volume":"12","author":"M Kolovrat","year":"2020","unstructured":"Kolovrat M, Gojkovic S, Krezic I et al (2020) Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. World J Hepatol 12(5):184\u2013206","journal-title":"World J Hepatol"},{"key":"1499_CR67","doi-asserted-by":"publisher","first-page":"9084643","DOI":"10.1155\/2019\/9084643","volume":"2019","author":"S Konosic","year":"2019","unstructured":"Konosic S, Petricevic M, Ivancan V et al (2019) Intragastric application of aspirin, clopidogrel, cilostazol and BPC 157 in rats: platelet aggregation and blood clot. Oxid Med Cell Longev 2019:9084643","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1499_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0889-8553(21)00456-8","volume":"19","author":"SJ Konturek","year":"1990","unstructured":"Konturek SJ (1990) Role of growth factors in gastroduodenal protection and healing of peptic ulcers. Gastroenterol Clin North Am 19(1):41\u201365","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"1499_CR69","first-page":"6","volume":"6","author":"PC Konturek","year":"2018","unstructured":"Konturek PC, Harsch IA, Konturek K et al (2018) Gut-liver axis: how do gut bacteria influence the liver? Med Sci 6(3):6","journal-title":"Med Sci"},{"issue":"1","key":"1499_CR70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/biomedicines10010089","volume":"10","author":"T Kralj","year":"2021","unstructured":"Kralj T, Kokot A, Zlatar M et al (2021) Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma. Biomedicines 10(1):89","journal-title":"Biomedicines"},{"issue":"5","key":"1499_CR71","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/jor.20096","volume":"24","author":"A Krivic","year":"2006","unstructured":"Krivic A, Anic T, Seiwerth S et al (2006) Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res 24(5):982\u2013989","journal-title":"J Orthop Res"},{"issue":"5","key":"1499_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00011-007-7056-8","volume":"57","author":"A Krivic","year":"2008","unstructured":"Krivic A, Majerovic M, Jelic I et al (2008) Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Inflamm Res 57(5):205\u2013210","journal-title":"Inflamm Res"},{"key":"1499_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH (2015) Antipsychotic medication in schizophrenia: a review. Br Med Bull 114:169\u2013179","journal-title":"Br Med Bull"},{"issue":"6","key":"1499_CR74","first-page":"E703","volume":"235","author":"C Lancaster","year":"1978","unstructured":"Lancaster C, Robert A (1978) Intestinal lesions produced by prednisolone: prevention (cytoprotection) by 16,16-dimethyl prostaglandin E2. Am J Physiol 235(6):E703\u2013E708","journal-title":"Am J Physiol"},{"issue":"2","key":"1499_CR75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000381990","volume":"130","author":"WL Lau","year":"2015","unstructured":"Lau WL, Kalantar-Zadeh K, Vaziri ND (2015) The gut as a source of inflammation in chronic kidney disease. Nephron 130(2):92\u201398","journal-title":"Nephron"},{"issue":"1","key":"1499_CR76","first-page":"321","volume":"29","author":"R Lazic","year":"2005","unstructured":"Lazic R, Gabric N, Dekaris I et al (2005) Gastric pentadecapeptide BPC 157 promotes corneal epithelial defects healing in rats. Coll Antropol 29(1):321\u2013325","journal-title":"Coll Antropol"},{"key":"1499_CR201","doi-asserted-by":"crossref","unstructured":"Li X, Atkinson MA (2015) The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept? Pediatr Diabetes 16(7):485\u2013492","DOI":"10.1111\/pedi.12305"},{"issue":"9","key":"1499_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162590","volume":"11","author":"N Lojo","year":"2016","unstructured":"Lojo N, Rasic Z, Zenko Sever A et al (2016) Effect of diclofenac, L-NAME, L-arginine, and pentadecapeptide BPC 157 on gastrointestinal, liver, and brain lesions, failed anastomosis, and intestinal adaptation deterioration in 24 hour-short-bowel rats. PLoS ONE 11(9):e0162590","journal-title":"PLoS ONE"},{"issue":"1","key":"1499_CR78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1254\/jphs.95.19","volume":"95","author":"M Lovric-Bencic","year":"2004","unstructured":"Lovric-Bencic M, Sikiric P, Hanzevacki JS et al (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC 157 in rat and mouse. J Pharmacol Sci 95(1):19\u201326","journal-title":"J Pharmacol Sci"},{"key":"1499_CR79","doi-asserted-by":"publisher","first-page":"6805354","DOI":"10.1155\/2020\/6805354","volume":"2020","author":"M Lozic","year":"2020","unstructured":"Lozic M, Stambolija V, Krezic I et al (2020) In relation to NO-system, stable pentadecapeptide BPC 157 coutneracts idocaine-induced adverse effects in rats and depolarisation in vitro. Emerg Med Int 2020:6805354","journal-title":"Emerg Med Int"},{"issue":"2","key":"1499_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10787-017-0330-7","volume":"25","author":"K Luetic","year":"2017","unstructured":"Luetic K, Sucic M, Vlainic J et al (2017) Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157. Inflammopharmacology 25(2):255\u2013264","journal-title":"Inflammopharmacology"},{"key":"1499_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exer.2015.04.016","volume":"136","author":"S Masnec","year":"2015","unstructured":"Masnec S, Kokot A, Zlatar M et al (2015) Perforating corneal injury in rat and pentadecapeptide BPC 157. Exp Eye Res 136:9\u201315","journal-title":"Exp Eye Res"},{"issue":"11","key":"1499_CR82","first-page":"282","volume":"2","author":"G Masson","year":"1938","unstructured":"Masson G, Selye H (1938) R\u00e9action g\u00e9n\u00e9rale d\u2019adaptation: Ses indications pratiques. Can J Comp Med (gard) 2(11):282\u2013285","journal-title":"Can J Comp Med (gard)"},{"issue":"4","key":"1499_CR83","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10787-017-0323-6","volume":"25","author":"M Medvidovic-Grubisic","year":"2017","unstructured":"Medvidovic-Grubisic M, Stambolija V, Kolenc D et al (2017) Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-Arginine worsen. Inflammopharmacology 25(4):439\u2013449","journal-title":"Inflammopharmacology"},{"key":"1499_CR84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.phrs.2018.04.023","volume":"133","author":"B Meijers","year":"2018","unstructured":"Meijers B, Jouret F, Evenepoel P (2018) Linking gut microbiota to cardiovascular disease and hypertension: lessons from chronic kidney disease. Pharmacol Res 133:101\u2013107","journal-title":"Pharmacol Res"},{"issue":"8","key":"1499_CR85","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0305-4179(01)00055-9","volume":"27","author":"D Mikus","year":"2001","unstructured":"Mikus D, Sikiric P, Seiwerth S et al (2001) Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns 27(8):817\u2013827","journal-title":"Burns"},{"key":"1499_CR86","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/157015909790031229","volume":"7","author":"R Miller","year":"2009","unstructured":"Miller R (2009) Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: PART I. Curr Neuropharmacol 7:302\u2013314","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1499_CR87","first-page":"394","volume":"59","author":"I Mirkovi\u0107","year":"2020","unstructured":"Mirkovi\u0107 I, Kralj T, Lozi\u0107 M et al (2020) Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats. Acta Clin Croat 59(3):394\u2013406","journal-title":"Acta Clin Croat"},{"issue":"4","key":"1499_CR88","first-page":"G342","volume":"242","author":"CB Nemeroff","year":"1982","unstructured":"Nemeroff CB, Hernandez DE, Orlando RC et al (1982) Cytoprotective effect of centrally administered neurotensin on stress-induced gastric ulcers. Am J Physiol 242(4):G342-346","journal-title":"Am J Physiol"},{"issue":"8","key":"1499_CR89","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s00595-007-3706-2","volume":"38","author":"T Novinscak","year":"2008","unstructured":"Novinscak T, Brcic L, Staresinic M et al (2008) Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. Surg Today 38(8):716\u2013725","journal-title":"Surg Today"},{"issue":"4","key":"1499_CR90","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/microorganisms6040107","volume":"6","author":"MEM Obrenovich","year":"2018","unstructured":"Obrenovich MEM (2018) Leaky gut, leaky brain? Microorganisms 6(4):6","journal-title":"Microorganisms"},{"issue":"3","key":"1499_CR91","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0149-7634(86)90017-5","volume":"10","author":"WP Par\u00e9","year":"1986","unstructured":"Par\u00e9 WP, Glavin GB (1986) Restraint stress in biomedical research: a review. Neurosci Biobehav Rev 10(3):339\u20133370","journal-title":"Neurosci Biobehav Rev"},{"issue":"25","key":"1499_CR92","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.2174\/1381612826666200523180301","volume":"26","author":"JM Park","year":"2020","unstructured":"Park JM, Lee HJ, Sikiric P, Hahm KB (2020) BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection. Curr Pharm Des 26(25):2971\u20132981","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1499_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13018-019-1242-6","volume":"14","author":"D Perovic","year":"2019","unstructured":"Perovic D, Kolenc D, Bilic V et al (2019) Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats. J Orthop Surg Res 14(1):19","journal-title":"J Orthop Surg Res"},{"issue":"5","key":"1499_CR94","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/cimb44050130","volume":"44","author":"D Perovic","year":"2022","unstructured":"Perovic D, Milavic M, Dokuzovic S et al (2022) Novel therapeutic effects in rat spinal cord injuries: recovery of the definitive and early spinal cord injury by the administration of pentadecapeptide BPC 157 therapy. Curr Issues Mol Biol 44(5):1901\u20131927","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"1499_CR95","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0928-4257(99)00120-5","volume":"93","author":"M Petek","year":"1999","unstructured":"Petek M, Sikiric P, Anic T et al (1999) Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice. J Physiol Paris 93(6):501\u2013504","journal-title":"J Physiol Paris"},{"issue":"3","key":"1499_CR96","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1254\/jphs.FP0060070","volume":"102","author":"I Petrovic","year":"2006","unstructured":"Petrovic I, Dobric I, Drvis P et al (2006) An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157. J Pharmacol Sci 102(3):269\u2013277","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"1499_CR97","first-page":"527","volume":"62","author":"I Petrovic","year":"2011","unstructured":"Petrovic I, Dobric I, Drmic D et al (2011) BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure. J Physiol Pharmacol 62(5):527\u2013534","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"1499_CR98","first-page":"BR1","volume":"16","author":"D Pevec","year":"2010","unstructured":"Pevec D, Novinscak T, Brcic L et al (2010) Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit 16(3):BR1-88","journal-title":"Med Sci Monit"},{"issue":"7","key":"1499_CR99","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/ph16070977","volume":"16","author":"I Premuzic Mestrovic","year":"2023","unstructured":"Premuzic Mestrovic I, Smoday IM, Kalogjera L et al (2023) Antiarrhythmic sotalol, occlusion\/occlusion-like syndrome in rats, and stable gastric pentadecapeptide BPC 157 therapy. Pharmaceuticals 16(7):977","journal-title":"Pharmaceuticals"},{"issue":"1\u20136","key":"1499_CR100","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0928-4257(01)00041-9","volume":"95","author":"I Prkacin","year":"2001","unstructured":"Prkacin I, Aralica G, Perovic D et al (2001a) Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. J Physiol Paris 95(1\u20136):295\u2013301","journal-title":"J Physiol Paris"},{"issue":"1\u20136","key":"1499_CR101","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0928-4257(01)00044-4","volume":"95","author":"I Prkacin","year":"2001","unstructured":"Prkacin I, Separovic J, Aralicia G et al (2001b) Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine. J Physiol Paris 95(1\u20136):315\u2013324","journal-title":"J Physiol Paris"},{"key":"1499_CR102","doi-asserted-by":"publisher","first-page":"A14","DOI":"10.1097\/00008390-200408000-00050","volume":"14","author":"S Radeljak","year":"2004","unstructured":"Radeljak S, Seiwerth S, Sikiric P (2004) BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line. Melanoma Res 14:A14\u2013A15","journal-title":"Melanoma Res"},{"issue":"9","key":"1499_CR103","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/biomedicines9091206","volume":"9","author":"D Rasic","year":"2021","unstructured":"Rasic D, Zenko Sever A, Rasic F et al (2021) Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats. Biomedicines 9(9):1206","journal-title":"Biomedicines"},{"key":"1499_CR104","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/j.1572-0241.2007.01255.x","volume":"102","author":"SC Reddymasu","year":"2007","unstructured":"Reddymasu SC, Soykan I, McCallum RW (2007) Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 102:2036\u20132045","journal-title":"Am J Gastroenterol"},{"issue":"4 Pt 1","key":"1499_CR105","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0016-5085(79)90235-X","volume":"77","author":"A Robert","year":"1979","unstructured":"Robert A (1979) Cytoprotection by prostaglandins. Gastroenterology 77(4 Pt 1):761\u2013767","journal-title":"Gastroenterology"},{"issue":"Suppl 7","key":"1499_CR106","first-page":"40","volume":"64","author":"A Robert","year":"1986","unstructured":"Robert A (1986) Cytoprotection and prostaglandins. Klin Wochenschr 64(Suppl 7):40\u201343","journal-title":"Klin Wochenschr"},{"issue":"1","key":"1499_CR107","doi-asserted-by":"crossref","first-page":"G113","DOI":"10.1152\/ajpcell.1983.245.1.C113","volume":"245","author":"A Robert","year":"1983","unstructured":"Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ (1983) Mild irritants prevent gastric necrosis through \u201cadaptive cytoprotection\u201d mediated by prostaglandins. Am J Physiol 245(1):G113\u2013G121","journal-title":"Am J Physiol"},{"issue":"5","key":"1499_CR108","first-page":"677","volume":"60","author":"A Robert","year":"1989","unstructured":"Robert A, Lum JT, Lancaster C, Olafsson AS, Kolbasa KP, Nezamis JE (1989) Prevention by prostaglandins of caerulein-induced pancreatitis in rats. Lab Invest 60(5):677\u2013691","journal-title":"Lab Invest"},{"issue":"Suppl. 1","key":"1499_CR109","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1097\/MCG.0000000000000255","volume":"48","author":"A Saggioro","year":"2014","unstructured":"Saggioro A (2014) Leaky gut, microbiota, and cancer: an incoming hypothesis. J Clin Gastroenterol 48(Suppl. 1):S62-66","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"1499_CR110","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S8756-3282(98)00180-X","volume":"24","author":"B Sebecic","year":"1999","unstructured":"Sebecic B, Nikolic V, Sikiric P et al (1999) Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone 24(3):195\u2013202","journal-title":"Bone"},{"issue":"3\u20135","key":"1499_CR111","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0928-4257(97)89480-6","volume":"91","author":"S Seiwerth","year":"1997","unstructured":"Seiwerth S, Sikiric P, Grabarevic Z et al (1997) BPC 157\u2019s effect on healing. J Physiol Paris 91(3\u20135):173\u2013178","journal-title":"J Physiol Paris"},{"key":"1499_CR112","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.2174\/1381612824666180712110447","volume":"24","author":"S Seiwerth","year":"2018","unstructured":"Seiwerth S, Rucman R, Turkovic B et al (2018) BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des 24:1972\u20131989","journal-title":"Curr Pharm Des"},{"key":"1499_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.627533","volume":"12","author":"S Seiwerth","year":"2021","unstructured":"Seiwerth S, Milavic M, Vukojevic J et al (2021) Stable gastric pentadecapeptide BPC 157 and wound healing. Front Pharmacol 12:627533","journal-title":"Front Pharmacol"},{"key":"1499_CR114","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/138032a0","volume":"138","author":"H Selye","year":"1936","unstructured":"Selye H (1936) A syndrome produced by diverse nocuous agents. Nature 138:32","journal-title":"Nature"},{"key":"1499_CR115","volume-title":"First annual report on stress","author":"H Selye","year":"1951","unstructured":"Selye H (1951) First annual report on stress. Acta Inc, Montreal"},{"key":"1499_CR116","volume-title":"The stress of life","author":"H Selye","year":"1956","unstructured":"Selye H (1956) The stress of life. McGraw-Hill, New York"},{"issue":"1","key":"1499_CR117","first-page":"53","volume":"115","author":"H Selye","year":"1976","unstructured":"Selye H (1976) Forty years of stress research: principal remaining problems and misconceptions. Can Med Assoc J 115(1):53\u201356","journal-title":"Can Med Assoc J"},{"issue":"5","key":"1499_CR118","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000093982","volume":"19","author":"D Seveljevi\u0107-Jaran","year":"2006","unstructured":"Seveljevi\u0107-Jaran D, Cuzi\u0107 S, Dominis-Kramari\u0107 M et al (2006) Accelerated healing of excisional skin wounds by PL 14736 in alloxan-hyperglycemic rats. Skin Pharmacol Physiol 19(5):266\u2013274","journal-title":"Skin Pharmacol Physiol"},{"issue":"10","key":"1499_CR119","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s10620-008-0598-y","volume":"54","author":"M Sever","year":"2009","unstructured":"Sever M, Klicek R, Radic B et al (2009) Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats. Dig Dis Sci 54(10):2070\u20132083","journal-title":"Dig Dis Sci"},{"key":"1499_CR120","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejphar.2019.01.030","volume":"847","author":"AZ Sever","year":"2019","unstructured":"Sever AZ, Sever M, Vidovic T et al (2019) Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation. Eur J Pharmacol 847:130\u2013142","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1499_CR121","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0928-4257(93)90038-U","volume":"87","author":"P Sikiri\u0107","year":"1993","unstructured":"Sikiri\u0107 P, Petek M, Rucman R et al (1993a) A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313\u2013327","journal-title":"J Physiol Paris"},{"issue":"18","key":"1499_CR122","doi-asserted-by":"publisher","first-page":"PL291","DOI":"10.1016\/0024-3205(93)90589-U","volume":"53","author":"P Sikiric","year":"1993","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (1993b) Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci 53(18):PL291\u2013PL296","journal-title":"Life Sci"},{"issue":"5","key":"1499_CR123","doi-asserted-by":"publisher","first-page":"PL63","DOI":"10.1016\/0024-3205(94)00796-9","volume":"54","author":"P Sikiric","year":"1994","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (1994) The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sci 54(5):PL63\u2013PL68","journal-title":"Life Sci"},{"issue":"7","key":"1499_CR124","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/BF02088582","volume":"41","author":"P Sikiric","year":"1996","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (1996a) Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig Dis Sci 41(7):1518\u20131526","journal-title":"Dig Dis Sci"},{"issue":"8","key":"1499_CR125","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/BF02087908","volume":"41","author":"P Sikiric","year":"1996","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (1996b) Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity. Dig Dis Sci 41(8):1604\u20131614","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1499_CR126","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1023\/A:1018880000644","volume":"42","author":"P Sikiric","year":"1997","unstructured":"Sikiric P, Mazul B, Seiwerth S et al (1997a) Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Dig Dis Sci 42(3):661\u2013671","journal-title":"Dig Dis Sci"},{"issue":"5","key":"1499_CR127","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1023\/A:1018893220943","volume":"42","author":"P Sikiric","year":"1997","unstructured":"Sikiric P, Mikus D, Seiwerth S et al (1997b) Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies. Dig Dis Sci 42(5):1029\u20131039","journal-title":"Dig Dis Sci"},{"key":"1499_CR128","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(97)01033-9","volume":"332","author":"P Sikiric","year":"1997","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (1997c) The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol 332:23\u201333","journal-title":"Eur J Pharmacol"},{"issue":"3\u20135","key":"1499_CR129","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0928-4257(97)89474-0","volume":"91","author":"P Sikiric","year":"1997","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (1997d) Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats. J Physiol Paris 91(3\u20135):113\u2013122","journal-title":"J Physiol Paris"},{"issue":"6","key":"1499_CR130","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0928-4257(99)00124-2","volume":"93","author":"P Sikiric","year":"1999","unstructured":"Sikiric P, Jadrijevic S, Seiwerth S et al (1999a) Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats. J Physiol Paris 93(6):467\u2013477","journal-title":"J Physiol Paris"},{"issue":"6","key":"1499_CR131","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0928-4257(99)00119-9","volume":"93","author":"P Sikiric","year":"1999","unstructured":"Sikiric P, Marovic A, Matoz W et al (1999b) A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson\u2019s disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine. J Physiol Paris 93(6):505\u2013512","journal-title":"J Physiol Paris"},{"issue":"1","key":"1499_CR132","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(98)00818-8","volume":"364","author":"P Sikiric","year":"1999","unstructured":"Sikiric P, Seiwerth S, Deskovic S et al (1999c) New model of cytoprotection\/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin. Eur J Pharmacol 364(1):23\u201331","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1499_CR133","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0928-4257(99)00123-0","volume":"93","author":"P Sikiric","year":"1999","unstructured":"Sikiric P, Separovic J, Anic T et al (1999d) The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. J Physiol Paris 93(6):479\u2013485","journal-title":"J Physiol Paris"},{"issue":"2","key":"1499_CR134","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0928-4257(00)00147-9","volume":"94","author":"P Sikiric","year":"2000","unstructured":"Sikiric P, Separovic J, Buljat G et al (2000) Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157. J Physiol Paris 94(2):105\u2013110","journal-title":"J Physiol Paris"},{"issue":"1\u20136","key":"1499_CR135","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0928-4257(01)00039-0","volume":"95","author":"P Sikiric","year":"2001","unstructured":"Sikiric P, Seiwerth S, Aralica G et al (2001a) Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat. J Physiol Paris 95(1\u20136):283\u2013288","journal-title":"J Physiol Paris"},{"issue":"16","key":"1499_CR136","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0928-4257(01)00036-5","volume":"95","author":"P Sikiric","year":"2001","unstructured":"Sikiric P, Seiwerth S, Grabarevic Z et al (2001b) Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone. J Physiol Paris 95(16):261\u2013270","journal-title":"J Physiol Paris"},{"issue":"4","key":"1499_CR137","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0305-4179(03)00004-4","volume":"29","author":"P Sikiric","year":"2003","unstructured":"Sikiric P, Seiwerth S, Mise S et al (2003) Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice. Burns 29(4):323\u2013334","journal-title":"Burns"},{"issue":"5\u20136","key":"1499_CR138","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s10787-006-1531-7","volume":"14","author":"P Sikiric","year":"2006","unstructured":"Sikiric P, Seiwerth S, Brcic L et al (2006) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia) Full and distended stomach, and vascular response. Inflammopharmacology 14(5\u20136):214\u2013221","journal-title":"Inflammopharmacology"},{"issue":"10","key":"1499_CR139","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/138161210790945977","volume":"16","author":"P Sikiric","year":"2010","unstructured":"Sikiric P, Seiwerth S, Brcic L et al (2010) Revised Robert\u2019s cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. Curr Pharm Des 16(10):1224\u20131234","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1499_CR140","first-page":"76","volume":"19","author":"P Sikiric","year":"2013","unstructured":"Sikiric P, Seiwerth S, Rucman R et al (2013) Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des 19(1):76\u201383","journal-title":"Curr Pharm Des"},{"key":"1499_CR141","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.2174\/13816128113190990411","volume":"20","author":"P Sikiric","year":"2014","unstructured":"Sikiric P, Seiwerth S, Rucman R et al (2014) Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des 20:1126\u20131135","journal-title":"Curr Pharm Des"},{"issue":"8","key":"1499_CR142","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/1570159X13666160502153022","volume":"14","author":"P Sikiric","year":"2016","unstructured":"Sikiric P, Seiwerth S, Rucman R et al (2016) Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Curr Neuropharmacol 14(8):857\u2013865","journal-title":"Curr Neuropharmacol"},{"issue":"27","key":"1499_CR143","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.2174\/1381612823666170220163219","volume":"23","author":"P Sikiric","year":"2017","unstructured":"Sikiric P, Seiwerth S, Rucman R et al (2017) Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157. Finally, do we have solution? Curr Pharm Des 23(27):4012\u20134028","journal-title":"Curr Pharm Des"},{"issue":"25","key":"1499_CR144","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.2174\/1381612826666200424180139","volume":"26","author":"P Sikiric","year":"2020","unstructured":"Sikiric P, Drmic D, Sever M et al (2020a) Fistula healing.1 Stable gastric pentadecapeptide BPC 157 therapy. Curr Pharm Des 26(25):2991\u20133000","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1499_CR145","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5009\/gnl18490","volume":"14","author":"P Sikiric","year":"2020","unstructured":"Sikiric P, Hahm KB, Blagaic AB et al (2020b) Stable gastric pentadecapeptide BPC 157, Robert\u2019s stomach cytoprotection\/adaptive cytoprotection\/organoprotection, and Selye\u2019s stress coping response: progress, achievements, and the future. Gut Liver 14(2):153\u2013167","journal-title":"Gut Liver"},{"issue":"1","key":"1499_CR146","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3748\/wjg.v28.i1.23","volume":"28","author":"P Sikiric","year":"2022","unstructured":"Sikiric P, Skrtic A, Gojkovic S et al (2022a) Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. World J Gastroenterol 28(1):23\u201346","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1499_CR147","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/biomedicines10112696","volume":"10","author":"P Sikiric","year":"2022","unstructured":"Sikiric P, Udovicic M, Barisic I et al (2022b) Stable gastric pentadecapeptide BPC 157 as useful cytoprotective peptide therapy in the heart disturbances, myocardial infarction, heart failure, pulmonary hypertension, arrhythmias, and thrombosis presentation. Biomedicines 10(11):2696","journal-title":"Biomedicines"},{"issue":"13","key":"1499_CR148","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.2174\/0929867329666221005111553","volume":"30","author":"P Sikiric","year":"2023","unstructured":"Sikiric P, Gojkovic S, Knezevic M et al (2023b) Stable gastric pentadecapeptide BPC 157: prompt particular activation of collateral pathways. Curr Med Chem 30(13):1568\u20131573","journal-title":"Curr Med Chem"},{"issue":"5","key":"1499_CR149","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/ph16050676","volume":"16","author":"P Sikiric","year":"2023","unstructured":"Sikiric P, Gojkovic S, Krezic I et al (2023c) Stable gastric pentadecapeptide BPC 157 may recover brain-gut axis and gut-brain axis function. Pharmaceuticals 16(5):676","journal-title":"Pharmaceuticals"},{"issue":"7","key":"1499_CR150","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/ph16071052","volume":"16","author":"P Sikiric","year":"2023","unstructured":"Sikiric P, Kokot A, Kralj T et al (2023d) Stable gastric pentadecapeptide VPC 157\u2013possible novel therapy of glaucoma and other ocular conditions. Pharmaceuticals 16(7):1052","journal-title":"Pharmaceuticals"},{"issue":"4","key":"1499_CR151","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ph17040461","volume":"17","author":"P Sikiric","year":"2024","unstructured":"Sikiric P, Boban Blagaic A, Strbe S et al (2024) The stable gastric pentadecapeptide BPC 157 pleiotropic beneficial activity and its possible relations with neurotransmitter activity. Pharmaceuticals 17(4):461","journal-title":"Pharmaceuticals"},{"key":"1499_CR152","doi-asserted-by":"crossref","unstructured":"Sikiric P, Drmic D, Boban Blagaic A, et al (2023a) Stable gastric pentadecapeptide BPC 157 and NO-system. In Nitric Oxide: From Research to Therapeutics; Ray A, Gulati K (eds) Advances in Biochemistry in Health and Disease 22. Springer Nature Switzerland AG: Cham, Switzerland, pp 349\u2013376","DOI":"10.1007\/978-3-031-24778-1_17"},{"issue":"1","key":"1499_CR153","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10620-008-0332-9","volume":"54","author":"S Skorjanec","year":"2009","unstructured":"Skorjanec S, Dolovski Z, Kocman I et al (2009) Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. Dig Dis Sci 54(1):46\u201356","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1499_CR154","first-page":"581","volume":"66","author":"S Skorjanec","year":"2015","unstructured":"Skorjanec S, Kokot A, Drmic D et al (2015) Duodenocutaneous fistula in rats as a model for \u201cwound healing-therapy\u201d in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine. J Physiol Pharmacol 66(4):581\u2013590","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"1499_CR155","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/biomedicines10061299","volume":"10","author":"IM Smoday","year":"2022","unstructured":"Smoday IM, Petrovic I, Kalogjera L et al (2022) Therapy effect of the stable gastric pentadecapeptide BPC 157 on acute pancreatitis as vascular failure-induced severe peripheral and central syndrome in rats. Biomedicines 10(6):1299","journal-title":"Biomedicines"},{"issue":"10","key":"1499_CR156","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/ph16101507","volume":"16","author":"IM Smoday","year":"2023","unstructured":"Smoday IM, Krezic I, Kalogjera L et al (2023) Pentadecapeptide BPC 157 as therapy for inferior caval vein embolization: recovery of sodium laurate-post-embolization syndrome in rats. Pharmaceuticals 16(10):1507","journal-title":"Pharmaceuticals"},{"key":"1499_CR157","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejphar.2016.04.004","volume":"781","author":"V Stambolija","year":"2016","unstructured":"Stambolija V, Stambolija TP, Holjevac JK et al (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias. Eur J Pharmacol 781:83\u201391","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"1499_CR158","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0928-4257(01)00040-7","volume":"95","author":"D Stancic-Rokotov","year":"2001","unstructured":"Stancic-Rokotov D, Sikiric P, Seiwerth S et al (2001a) Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents. J Physiol Paris 95(16):289\u2013293","journal-title":"J Physiol Paris"},{"issue":"1\u20136","key":"1499_CR159","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0928-4257(01)00042-0","volume":"95","author":"D Stancic-Rokotov","year":"2001","unstructured":"Stancic-Rokotov D, Slobodnjak Z, Aralica J et al (2001b) Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats. J Physiol Paris 95(1\u20136):303\u2013308","journal-title":"J Physiol Paris"},{"issue":"6","key":"1499_CR160","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S0736-0266(03)00110-4","volume":"21","author":"M Staresinic","year":"2003","unstructured":"Staresinic M, Sebecic B, Patrlj L et al (2003) Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res 21(6):976\u2013983","journal-title":"J Orthop Res"},{"issue":"5","key":"1499_CR161","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/jor.20089","volume":"24","author":"M Staresinic","year":"2006","unstructured":"Staresinic M, Petrovic I, Novinscak T et al (2006) Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157. J Orthop Res 24(5):1109\u20131117","journal-title":"J Orthop Res"},{"issue":"12","key":"1499_CR162","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.3390\/biomedicines10123221","volume":"10","author":"M Staresinic","year":"2022","unstructured":"Staresinic M, Japjec M, Vranes H et al (2022) Stable gastric pentadecapeptide BPC 157 and striated smooth and heart muscle. Biomedicines 10(12):3221","journal-title":"Biomedicines"},{"issue":"11","key":"1499_CR163","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/biomedicines9111506","volume":"9","author":"S Strbe","year":"2021","unstructured":"Strbe S, Gojkovic S, Krezic I et al (2021) Over-dose lithium toxicity as an occlusive-like syndrome in rats and gastric pentadecapeptide BPC 157. Biomedicines 9(11):1506","journal-title":"Biomedicines"},{"issue":"6","key":"1499_CR164","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/ph16060788","volume":"16","author":"S Strbe","year":"2023","unstructured":"Strbe S, Smoday IM, Krezic I et al (2023) Innate vascular failure by application of neuroleptics, amphetamine, and domperidone rapidly induced severe occlusion\/occlusion-like syndromes in rats and stable gastric pentadecapeptide BPC 157 as therapy. Pharmaceuticals 16(6):788","journal-title":"Pharmaceuticals"},{"key":"1499_CR165","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.lfs.2017.08.006","volume":"186","author":"D Strinic","year":"2017","unstructured":"Strinic D, Belosic Halle Z, Luetic K et al (2017) BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats. Life Sci 186:66\u201379","journal-title":"Life Sci"},{"key":"1499_CR166","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/bs.apha.2021.07.001","volume":"93","author":"A Strzelecki","year":"2022","unstructured":"Strzelecki A, Weafer J, Stoops WW (2022) Human behavioral pharmacology of stimulant drugs: an update and narrative review. Adv Pharmacol 93:77\u2013103","journal-title":"Adv Pharmacol"},{"issue":"5","key":"1499_CR167","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.thromres.2011.07.035","volume":"129","author":"M Stupnisek","year":"2012","unstructured":"Stupnisek M, Franjic S, Drmic D et al (2012) Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin. Thromb Res 129(5):652\u2013659","journal-title":"Thromb Res"},{"issue":"4","key":"1499_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123454","volume":"10","author":"M Stupnisek","year":"2015","unstructured":"Stupnisek M, Kokot A, Drmic D et al (2015) Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin L-NAME and L-Arginine. PLoS ONE 10(4):e0123454","journal-title":"PLoS ONE"},{"key":"1499_CR169","doi-asserted-by":"publisher","first-page":"172593","DOI":"10.1016\/j.ejphar.2019.172593","volume":"861","author":"M Sucic","year":"2019","unstructured":"Sucic M, Luetic K, Jandric I et al (2019) Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine. L-NAME. Eur J Pharmacol 861:172593","journal-title":"L-NAME. Eur J Pharmacol"},{"issue":"2","key":"1499_CR170","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/BF01945097","volume":"38","author":"S Szabo","year":"1982","unstructured":"Szabo S, Usadel KH (1982) Cytoprotection - organoprotection by somatostatin: gastric and hepatic lesions. Experientia 38(2):254\u2013256","journal-title":"Experientia"},{"issue":"1 Pt 2","key":"1499_CR171","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0016-5085(85)80176-1","volume":"88","author":"S Szabo","year":"1985","unstructured":"Szabo S, Trier JS, Brown A, Schnoor J (1985) Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 88(1 Pt 2):228\u2013236","journal-title":"Gastroenterology"},{"issue":"2A","key":"1499_CR172","doi-asserted-by":"publisher","first-page":"158S","DOI":"10.1016\/0002-9343(91)90469-E","volume":"91","author":"S Szabo","year":"1991","unstructured":"Szabo S, Vattay P, Scarbrough E et al (1991) Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am J Med 91(2A):158S-160S","journal-title":"Am J Med"},{"issue":"16","key":"1499_CR173","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2174\/138161211796197034","volume":"17","author":"S Szabo","year":"2011","unstructured":"Szabo S, Deng X, Tolstanova G et al (2011) Angiogenic and anti-angiogenic therapy for gastrointestinal ulcers: new challenges for rational therapeutic predictions and drug design. Curr Pharm Des 17(16):1633\u20131642","journal-title":"Curr Pharm Des"},{"issue":"27","key":"1499_CR174","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.2174\/1381612823666170622110046","volume":"23","author":"S Szabo","year":"2017","unstructured":"Szabo S, Yoshida M, Filakovszky J et al (2017) \u201cStress\u201d is 80 years old: from Hanse Selye original paper in 1936 to recent advances in GI ulceration. Curr Pharm Des 23(27):4029\u20134041","journal-title":"Curr Pharm Des"},{"key":"1499_CR175","doi-asserted-by":"crossref","unstructured":"Szabo S, Tache Y, Tarnawski AT (2012) The \u201egastric cytoprotection\u201c concept of Andre Robert and the origins of a new series of international symposia. In: Filaretova LP, Takeuchi K (eds): Cell\/Tissue Injury and Cytoprotection\/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Front Gastrointest Res. Basel, Karger, vol 30, pp 1\u201323","DOI":"10.1159\/000338742"},{"key":"1499_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.718147","volume":"12","author":"M Tepes","year":"2021","unstructured":"Tepes M, Gojkovic S, Krezic I et al (2021) Stable gastric pentadecapeptide BPC 157 therapy for primary abdominal compartment syndrome in rats. Front Pharmacol 12:718147","journal-title":"Front Pharmacol"},{"key":"1499_CR177","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/ph16111554","volume":"16","author":"M Tepes","year":"2023","unstructured":"Tepes M, Krezic I, Vranes H et al (2023) Stable gastric pentadecapeptide BPC 157 therapy: effect on reperfusion following maintained intra-abdominal hypertension (grade III and IV) in rats. Pharmaceuticals 16:1554","journal-title":"Pharmaceuticals"},{"issue":"1\u20133","key":"1499_CR178","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejphar.2007.05.072","volume":"570","author":"VI Tkalcevi\u0107","year":"2007","unstructured":"Tkalcevi\u0107 VI, Cuzi\u0107 S, Brajsa K et al (2007) Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur J Pharmacol 570(1\u20133):212\u2013221","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1499_CR179","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/jvp.12509","volume":"41","author":"I Tlak Gajger","year":"2018","unstructured":"Tlak Gajger I, Ribari\u0107 J, Smodi\u0161 \u0160kerl M, Vlaini\u0107 J, Sikiri\u0107 P (2018) Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions. J Vet Pharmacol Ther 41(4):614\u2013621","journal-title":"J Vet Pharmacol Ther"},{"issue":"9","key":"1499_CR180","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/biology10090891","volume":"10","author":"I Tlak Gajger","year":"2021","unstructured":"Tlak Gajger I, Smodi\u0161 \u0160kerl MI, \u0160o\u0161tari\u0107 P, \u0160uran J, Sikiri\u0107 P, Vlaini\u0107 J (2021) Physiological and immunological status of adult honeybees (Apis mellifera) fed sugar syrup supplemented with pentadecapeptide BPC 157. Biology 10(9):891","journal-title":"Biology"},{"issue":"1\u20133","key":"1499_CR181","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.regpep.2009.11.012","volume":"160","author":"M Tudor","year":"2010","unstructured":"Tudor M, Jandric I, Marovic A et al (2010) Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul Pept 160(1\u20133):26\u201332","journal-title":"Regul Pept"},{"key":"1499_CR182","first-page":"287","volume":"126","author":"B Turkovic","year":"2004","unstructured":"Turkovic B, Sikiric P, Seiwerth S, Mise S, Anic T, Petek M (2004) Stable gastric pentadecapeptide BPC 157 studied for inflammatory bowel disease (PLD-116, PL14736, Pliva) induces nitric oxide synthesis. Gastroenterology 126:287","journal-title":"Gastroenterology"},{"issue":"7","key":"1499_CR183","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/biomedicines9070822","volume":"9","author":"M Udovicic","year":"2021","unstructured":"Udovicic M, Sever M, Kavur L et al (2021) Stable gastric pentadecapeptide BPC 157 therapy for monocrotaline-induced pulmonary hypertension in rats leads to prevention and reversal. Biomedicines 9(7):822","journal-title":"Biomedicines"},{"issue":"1","key":"1499_CR184","first-page":"417","volume":"272","author":"M Veljaca","year":"1994","unstructured":"Veljaca M, Lech CA, Pllana R et al (1994) BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 272(1):417\u2013422","journal-title":"J Pharmacol Exp Ther"},{"key":"1499_CR185","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0016-5085(95)27355-7","volume":"108","author":"M Veljaca","year":"1995","unstructured":"Veljaca M, Chan K, Guglietta A (1995) Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice. Gastroenterology 108:761","journal-title":"Gastroenterology"},{"issue":"2","key":"1499_CR186","first-page":"265","volume":"68","author":"S Vitaic","year":"2017","unstructured":"Vitaic S, Stupnisek M, Drmic D et al (2017) Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gastric pentadecapeptide BPC 157 in rats. J Physiol Pharmacol 68(2):265\u2013272","journal-title":"J Physiol Pharmacol"},{"key":"1499_CR187","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vph.2018.02.010","volume":"106","author":"J Vukojevi\u0107","year":"2018","unstructured":"Vukojevi\u0107 J, Siroglavi\u0107 M, Ka\u0161nik K et al (2018) Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Vascul Pharmacol 106:54\u201366","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"1499_CR188","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1726","volume":"10","author":"J Vukojevi\u0107","year":"2020","unstructured":"Vukojevi\u0107 J, Vrdoljak B, Malekinu\u0161i\u0107 D et al (2020) The effect of pentadecapeptide BPC 157 on hippocampal ischemia\/reperfusion injuries in rats. Brain Behav 10(8):e01726","journal-title":"Brain Behav"},{"issue":"9","key":"1499_CR189","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s00595-006-3498-9","volume":"37","author":"T Vuksic","year":"2007","unstructured":"Vuksic T, Zoricic I, Brcic L et al (2007) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat. Surg Today 37(9):768\u2013777","journal-title":"Surg Today"},{"issue":"1","key":"1499_CR190","first-page":"89","volume":"75","author":"D Vukusic","year":"2024","unstructured":"Vukusic D, Zenko Sever A, Sever M et al (2024) Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint. J Physiol Pharmacol 75(1):89\u2013104","journal-title":"J Physiol Pharmacol"},{"key":"1499_CR191","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12264-018-0269-8","volume":"35","author":"XY Wang","year":"2019","unstructured":"Wang XY, Qu M, Duan R et al (2019) Cytoprotective mechanism of the novel gastric peptide BPC157 in gastrointestinal tract and cultured enteric neurons and glial cells. Neurosci Bull 35:167\u2013170","journal-title":"Neurosci Bull"},{"key":"1499_CR192","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.2147\/DDDT.S284163","volume":"14","author":"H Wu","year":"2020","unstructured":"Wu H, Wei M, Li N et al (2020) Clopidogrel-induced gastric injury in rats is attenuated by stable gastric pentadecapeptide BPC 157. Drug Des Devel Ther 14:5599\u20135610","journal-title":"Drug Des Devel Ther"},{"key":"1499_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104665","volume":"114","author":"C Xu","year":"2020","unstructured":"Xu C, Sun L, Ren F et al (2020) Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regul Toxicol Pharmacol 114:104665","journal-title":"Regul Toxicol Pharmacol"},{"issue":"7","key":"1499_CR194","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3748\/wjg.v10.i7.1032","volume":"10","author":"XC Xue","year":"2004","unstructured":"Xue XC, Wu YJ, Gao MT et al (2004) Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol 10(7):1032\u20131036","journal-title":"World J Gastroenterol"},{"key":"1499_CR195","doi-asserted-by":"publisher","first-page":"112919","DOI":"10.1016\/j.bbr.2020.112919","volume":"396","author":"A Zemba Cilic","year":"2021","unstructured":"Zemba Cilic A, Zemba M, Cilic M et al (2021) Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling \u201cpositive-like\u201d symptoms of schizophrenia. Behav Brain Res 396:112919","journal-title":"Behav Brain Res"},{"issue":"7","key":"1499_CR196","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/biomedicines10071462","volume":"10","author":"A Zemba Cilic","year":"2022","unstructured":"Zemba Cilic A, Zemba M, Cilic M et al (2022) BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat ketamine models resembling \u201enegative-like\u201c symptoms of schizophrenia. Biomedicines 10(7):1462","journal-title":"Biomedicines"},{"key":"1499_CR197","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejphar.2016.10.035","volume":"793","author":"G Zivanovic-Posilovic","year":"2016","unstructured":"Zivanovic-Posilovic G, Balenovic D, Barisic I et al (2016) Stable gastric pentadecapeptide BPC 157 and bupivacaine. Eur J Pharmacol 793:56\u201365","journal-title":"Eur J Pharmacol"},{"key":"1499_CR198","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.632295","volume":"12","author":"M Zlatar","year":"2021","unstructured":"Zlatar M, Kokot A, Vuletic LB et al (2021) BPC 157 as a therapy for retinal ischemia induced by retrobulbar application of L-NAME in rats. Front Pharmacol 12:632295","journal-title":"Front Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01499-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01499-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01499-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T17:03:54Z","timestamp":1726938234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01499-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":201,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1499"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01499-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}